3-36993548-A-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001167617.3(MLH1):c.-516A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001167617.3 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Colonic neoplasm Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.M1? pathogenic mutation (also known as c.1A>T), located in coding exon 1 of the MLH1 gene, results from an A to T substitution at nucleotide position 1. This alters the methionine residue at the initiation codon (ATG). This variant has been reported in an individual with colorectal cancer who underwent cancer multi-gene testing (Akcay IM et al. Int J Cancer, 2021 01;148:285-295). Another alteration affecting the initiation codon, p.M1? (c.3G>A), has been detected in multiple Lynch syndrome families meeting Amsterdam criteria (Guillem JG et al. Ann Surg. 2007 Apr;245(4):560-5; Ambry internal data). Sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.